Share this article
Share this article
ResearchAndMarkets.com s offering.
The Single-cell Sequencing Services and Technologies Market, 2020-2030 report features an extensive study of the current landscape and the future opportunities associated with single-cell sequencing services/technologies.
One of the key objectives of the report was to understand the primary growth drivers and estimate the future opportunity within the market. Based on several parameters, such as number of single-cell samples sequenced annually, average cost of sequencing, and growth trends across various geographies, we have provided an informed estimate of the likely evolution of the market, in the mid to long term, for the period 2020-2030.
(2)
SALT LAKE CITY, Utah, Dec. 22, 2020 (GLOBE NEWSWIRE) Green Star Products, Inc. (USOTC: GSPI) announced on December 18
th it received new data from a US Federally Accredited Laboratory stating, In three replications at 3% and 10% concentration [of normal dosage of Viro Spectrum Shield], 100% of the cells were protected from signs of infection by the SARS-CoV-2 [COVID-19] virus,
in vitro .
Additionally, Viro Spectrum Shield (VSS) was specifically tested and found to be effective against the COVID-19 virus as well as the A/H1N1, A/H2N3, B/H2N3 flu viruses
in vitro, which demonstrates its Broad-Spectrum Antiviral Capability. VSS was also tested and found to be non-toxic
Green Star Products: New Research Data Indicates 99.9% Effective Against the COVID-19 Virus
SALT LAKE CITY, Utah, Dec. 22, 2020 (GLOBE NEWSWIRE) Green Star Products, Inc. (USOTC: GSPI) announced on December 18
th it received new data from a US Federally Accredited Laboratory stating, In three replications at 3% and 10% concentration [of normal dosage of Viro Spectrum Shield], 100% of the cells were protected from signs of infection by the SARS-CoV-2 [COVID-19] virus,
in vitro .
Additionally, Viro Spectrum Shield (VSS) was specifically tested and found to be effective against the COVID-19 virus as well as the A/H1N1, A/H2N3, B/H2N3 flu viruses
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Green Star Products: New Research Data Indicates 99.9% Effective Against the COVID-19 Virus
Green Star Products, IncDecember 18, 2020 GMT
SALT LAKE CITY, UT, Dec. 18, 2020 (GLOBE NEWSWIRE) Green Star Products, Inc. (USOTC: GSPI) today announced it received new data from a US Federally Accredited Laboratory stating, “In three replications at 3% and 10% concentration [of normal dosage of Viro Spectrum Shield], 100% of the cells were protected from signs of infection by the SARS-CoV-2 [COVID-19] virus,
in vitro ”.
Additionally, Viro Spectrum Shield (VSS) was specifically tested and found to be effective against the COVID-19 virus as well as the A/H1N1, A/H2N3, B/H2N3 flu viruses
Green Star Products Signs Covid-19 Distribution Contract
SALT LAKE CITY, UT, Dec. 14, 2020 (GLOBE NEWSWIRE) Last Friday, December 11, 2020, Joseph LaStella, President of Green Star Products, Inc. (OTC: GSPI) announced he signed a Distribution Contract with Biotech Research, LLC, to market/sell their Broad-Spectrum Antiviral Product, called Viro Spectrum Shield (VSS), in several South American countries.
VSS has been tested by a US Federally Accredited Laboratory and has been successfully proven to inhibit SARS-CoV-2 (Covid-19) virus
in vitro.
VSS was specifically tested and found to be effective against the Covid-19 virus as well as the A/H1N1, A/H2N3, B/H2N3 flu viruses